LINDA BACK: Open Payments
NPI 1922870021 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,424 in 142 payments from 22 companies in 2025. Trend: 2023 $93 · 2024 $2,325 · 2025 $3,424
Food & beverage: $3,424
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $645 |
| UCB, Inc. | 20 | $579 |
| PFIZER INC. | 13 | $324 |
| AstraZeneca Pharmaceuticals LP | 9 | $280 |
| Amgen Inc. | 17 | $246 |
| Mallinckrodt Hospital Products Inc. | 7 | $220 |
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| Radius Health, Inc. | 6 | $176 |
| Janssen Biotech, Inc. | 7 | $141 |
| GlaxoSmithKline, LLC. | 5 | $130 |
Products named: Bimzelx, RINVOQ, SAPHNELO, XELJANZ, ACTHAR, Tymlos, COSENTYX, TREMFYA.
Industry payments across AL — which companies pay providers there.
